Suscribirse

Association Between E-Cigarette Use and Cardiovascular Disease Among Never and Current Combustible-Cigarette Smokers - 09/09/19

Doi : 10.1016/j.amjmed.2019.02.016 
Albert D. Osei, MD, MPH a, b, Mohammadhassan Mirbolouk, MD a, b, Olusola A. Orimoloye, MD, MPH a, b, Omar Dzaye, MD, PhD b, c, S.M. Iftekhar Uddin, MBBS, MSPH a, b, Emelia J. Benjamin, MD, ScM a, d, Michael E. Hall, MD, MSc a, e, Andrew P. DeFilippis, MD, MSc a, f, Andrew Stokes, PhD a, d, Aruni Bhatnagar, PhD a, f, Khurram Nasir, MD, MPH g, Michael J. Blaha, MD, MPH a, b,
a The American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas 
b Johns Hopkins University, Baltimore, Md 
c Department of Radiology and Neuroradiology, Charité, Berlin, Germany 
d Boston University, Mass 
e University of Mississippi Medical Center, Jackson 
f University of Louisville, Ky 
g Center for Outcomes Research and Evaluation (CORE), Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Conn 

Requests for reprints should be addressed to Michael J. Blaha, MD, MPH, Johns Hopkins University, Blalock 524D1 JHH, 600 N Wolfe St, Baltimore, MD 21287.Johns Hopkins UniversityBlalock 524D1 JHH, 600 N Wolfe StBaltimoreMD21287

Abstract

Background

The prevalence of e-cigarette use in the United States has increased rapidly. However, the association between e-cigarette use and cardiovascular disease remains virtually unknown. Therefore, we aimed to examine the association between e-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers.

Methods

We pooled 2016 and 2017 data from the Behavioral Risk Factor Surveillance System (BRFSS), a large, nationally representative, cross-sectional telephone survey. We included 449,092 participants with complete self-reported information on all key variables. The main exposure, e-cigarette use, was further divided into daily or occasional use, and stratified by combustible-cigarette use (never and current). Cardiovascular disease, the main outcome, was defined as a composite of self-reported coronary heart disease, myocardial infarction, or stroke.

Results

Of 449,092 participants, there were 15,863 (3.5%) current e-cigarette users, 12,908 (2.9%) dual users of e-cigarettes + combustible cigarettes, and 44,852 (10.0%) with cardiovascular disease. We found no significant association between e-cigarette use and cardiovascular disease among never combustible-cigarette smokers. Compared with current combustible-cigarette smokers who never used e-cigarettes, dual use of e-cigarettes + combustible cigarettes was associated with 36% higher odds of cardiovascular disease (odds ratio 1.36; 95% confidence interval, 1.18-1.56); with consistent results in subgroup analyses of premature cardiovascular disease in women <65 years and men <55 years old.

Conclusion

Our results suggest significantly higher odds of cardiovascular disease among dual users of e-cigarettes + combustible cigarettes compared with smoking alone. These data, although preliminary, support the critical need to conduct longitudinal studies exploring cardiovascular disease risk associated with e-cigarette use, particularly among dual users.

El texto completo de este artículo está disponible en PDF.

Keywords : Cardiovascular disease, Combustible cigarettes, Dual use, E-cigarettes


Esquema


 Funding: American Heart Association Tobacco Regulation and Addiction Center, 2U54HL120163, which is funded by the U.S. Food and Drug Administration and National Heart, Lung, and Blood Institute.
 Conflict of Interest: EJB has received the following grant: P50 HL120163 (Robertson, Bhatnagar), 09/01/18-06/30/23, American Heart Association (AHA)/National Institutes of Health, AHA Tobacco Regulation and Addiction Center (ATRAC); EJB is the primary investigator on the Training Core (Core D).
 Authorship: All authors had access to the data and played a role in writing the manuscript.


© 2019  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 132 - N° 8

P. 949 - août 2019 Regresar al número
Artículo precedente Artículo precedente
  • Association of Thrombocytopenia, Revascularization, and In-Hospital Outcomes in Patients with Acute Myocardial Infarction
  • Gregory D. Rubinfeld, Nathaniel R. Smilowitz, Jeffrey S. Berger, Jonathan D. Newman
| Artículo siguiente Artículo siguiente
  • Iron Supplementation Improves Cardiovascular Outcomes in Patients with Heart Failure
  • Xiang Zhou, Weiting Xu, Youjia Xu, Zhiyuan Qian

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.